HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NBIA2B

mutation in PLA2G6

Also Known As:

Neuroaxonal Dystrophy, Atypical; Neurodegeneration With Brain Iron Accumulation 2B; Neurodegeneration With Brain Iron Accumulation, PLA2G6-Related

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
- Central Nervous System Diseases: 4213
  - Brain Diseases: 15694
    - Neuroaxonal Dystrophies: 166
      - NBIA2B: 2
Nutritional and Metabolic Diseases: 15
- Metabolic Diseases: 10142
  - Iron Metabolism Disorders: 78
    - NBIA2B: 2

Related Diseases

1.	Parkinsonian Disorders (Parkinsonism)
2.	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)
3.	Dystonia (Limb Dystonia)
4.	Neurodegenerative Diseases (Neurodegenerative Disease)

Experts

1.	Balint, Bettina: 1 article (01/2017)
2.	Barone, Paolo: 1 article (01/2017)
3.	Bhatia, Kailash P: 1 article (01/2017)
4.	Brugger, Florian: 1 article (01/2017)
5.	Erro, Roberto: 1 article (01/2017)
6.	Kurian, Manju A: 1 article (01/2017)
7.	Pellecchia, Maria Teresa: 1 article (01/2017)
8.	Picillo, Marina: 1 article (01/2017)
9.	Bilgic, Basar: 1 article (01/2016)
10.	Erginul-Unaltuna, Nihan: 1 article (01/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to NBIA2B:

1.

01/01/2017 - "PLA2G6-associated neurodegeneration comprises a heterogeneous spectrum of age-related phenotypes, with three forms classically recognized, including infantile neuroaxonal dystrophy (INAD) with onset in infancy, atypical neuroaxonal dystrophy (atypical NAD) with onset in childhood, and dystonia-parkinsonism (PARK14) with onset in early adulthood. "
01/01/2016 - "PLA2G6-associated neurodegeneration (PLAN) is a recessive neurodegenerative disorder characterized by three distinct phenotypes: infantile neuroaxonal dystrophy (INAD), atypical neuroaxonal dystrophy (atypical NAD), and PLA2G6-related dystonia-parkinsonism. "